SaverOne 2014 (SVRE) shares were up 59% pre-bell Monday following a muted session.
Sonnet BioTherapeutics (SONN) shares were 31% higher after a 5.5% loss in the previous session.
Apogee Therapeutics (APGE) stock was up 20% after the company said that part A of a phase 2 trial of APG777 in patients with moderate-to-severe atopic dermatitis met all primary and key secondary endpoints.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.